カテゴリ： 世界, 医療/バイオ, Market Monitor Global

メンクス症候群のグローバル市場展望 2023年-2029年：遺伝子治療、銅注射療法

■ 英語タイトル：Menkes Syndrome Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC12394）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC12394
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療
■ ページ数：66
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[メンクス症候群のグローバル市場展望 2023年-2029年：遺伝子治療、銅注射療法]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のメンクス症候群市場規模と予測を収録しています。・世界のメンクス症候群市場：売上、2018年-2023年、2024年-2029年
・世界のメンクス症候群市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のメンクス症候群市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「遺伝子治療」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

メンクス症候群のグローバル主要企業は、Fortress Biotech、 Teva Pharmaceutical Industries Ltd、 Amerigen Pharmaceuticals Limited、 Mylan N.V.、 Bausch Health、 H. Lundbeck A/Sなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、メンクス症候群のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のメンクス症候群市場：タイプ別、2018年-2023年、2024年-2029年
世界のメンクス症候群市場：タイプ別市場シェア、2022年
・遺伝子治療、銅注射療法

世界のメンクス症候群市場：用途別、2018年-2023年、2024年-2029年
世界のメンクス症候群市場：用途別市場シェア、2022年
・診療所、病院、その他

世界のメンクス症候群市場：地域・国別、2018年-2023年、2024年-2029年
世界のメンクス症候群市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるメンクス症候群のグローバル売上、2018年-2023年
・主要企業におけるメンクス症候群のグローバル売上シェア、2022年
・主要企業におけるメンクス症候群のグローバル販売量、2018年-2023年
・主要企業におけるメンクス症候群のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Fortress Biotech、 Teva Pharmaceutical Industries Ltd、 Amerigen Pharmaceuticals Limited、 Mylan N.V.、 Bausch Health、 H. Lundbeck A/S

*************************************************************

・調査・分析レポートの概要
メンクス症候群市場の定義
市場セグメント
世界のメンクス症候群市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のメンクス症候群市場規模
世界のメンクス症候群市場規模：2022年 VS 2029年
世界のメンクス症候群市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのメンクス症候群の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のメンクス症候群製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：遺伝子治療、銅注射療法
メンクス症候群のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：診療所、病院、その他
メンクス症候群の用途別グローバル売上・予測

・地域別市場分析
地域別メンクス症候群市場規模 2022年と2029年
地域別メンクス症候群売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Fortress Biotech、 Teva Pharmaceutical Industries Ltd、 Amerigen Pharmaceuticals Limited、 Mylan N.V.、 Bausch Health、 H. Lundbeck A/S
...

This research report provides a comprehensive analysis of the Menkes Syndrome market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Menkes Syndrome market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Menkes Syndrome, challenges faced by the industry, and potential opportunities for market players.
The global Menkes Syndrome market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Menkes Syndrome market presents opportunities for various stakeholders, including Clinic, Hospital. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Menkes Syndrome market. Additionally, the growing consumer demand present avenues for market expansion.
The global Menkes Syndrome market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Menkes Syndrome market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Menkes Syndrome market.
Market Overview: The report provides a comprehensive overview of the Menkes Syndrome market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Gene Therapy, Copper Injection Therapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Menkes Syndrome market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Menkes Syndrome market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Menkes Syndrome market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Menkes Syndrome market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Menkes Syndrome market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Menkes Syndrome market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Menkes Syndrome, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Menkes Syndrome market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Menkes Syndrome market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Gene Therapy
Copper Injection Therapy
Market segment by Application
Clinic
Hospital
Others
Global Menkes Syndrome Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Fortress Biotech
Teva Pharmaceutical Industries Ltd
Amerigen Pharmaceuticals Limited
Mylan N.V.
Bausch Health
H. Lundbeck A/S
Outline of Major Chapters:
Chapter 1: Introduces the definition of Menkes Syndrome, market overview.
Chapter 2: Global Menkes Syndrome market size in revenue.
Chapter 3: Detailed analysis of Menkes Syndrome company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Menkes Syndrome in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Menkes Syndrome Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Menkes Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Menkes Syndrome Overall Market Size
2.1 Global Menkes Syndrome Market Size: 2022 VS 2029
2.2 Global Menkes Syndrome Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Menkes Syndrome Players in Global Market
3.2 Top Global Menkes Syndrome Companies Ranked by Revenue
3.3 Global Menkes Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Menkes Syndrome Companies in Global Market, by Revenue in 2022
3.5 Global Companies Menkes Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Menkes Syndrome Players in Global Market
3.6.1 List of Global Tier 1 Menkes Syndrome Companies
3.6.2 List of Global Tier 2 and Tier 3 Menkes Syndrome Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Menkes Syndrome Market Size Markets, 2022 & 2029
4.1.2 Gene Therapy
4.1.3 Copper Injection Therapy
4.2 By Type – Global Menkes Syndrome Revenue & Forecasts
4.2.1 By Type – Global Menkes Syndrome Revenue, 2018-2023
4.2.2 By Type – Global Menkes Syndrome Revenue, 2024-2029
4.2.3 By Type – Global Menkes Syndrome Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Menkes Syndrome Market Size, 2022 & 2029
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application – Global Menkes Syndrome Revenue & Forecasts
5.2.1 By Application – Global Menkes Syndrome Revenue, 2018-2023
5.2.2 By Application – Global Menkes Syndrome Revenue, 2024-2029
5.2.3 By Application – Global Menkes Syndrome Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Menkes Syndrome Market Size, 2022 & 2029
6.2 By Region – Global Menkes Syndrome Revenue & Forecasts
6.2.1 By Region – Global Menkes Syndrome Revenue, 2018-2023
6.2.2 By Region – Global Menkes Syndrome Revenue, 2024-2029
6.2.3 By Region – Global Menkes Syndrome Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Menkes Syndrome Revenue, 2018-2029
6.3.2 US Menkes Syndrome Market Size, 2018-2029
6.3.3 Canada Menkes Syndrome Market Size, 2018-2029
6.3.4 Mexico Menkes Syndrome Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Menkes Syndrome Revenue, 2018-2029
6.4.2 Germany Menkes Syndrome Market Size, 2018-2029
6.4.3 France Menkes Syndrome Market Size, 2018-2029
6.4.4 U.K. Menkes Syndrome Market Size, 2018-2029
6.4.5 Italy Menkes Syndrome Market Size, 2018-2029
6.4.6 Russia Menkes Syndrome Market Size, 2018-2029
6.4.7 Nordic Countries Menkes Syndrome Market Size, 2018-2029
6.4.8 Benelux Menkes Syndrome Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Menkes Syndrome Revenue, 2018-2029
6.5.2 China Menkes Syndrome Market Size, 2018-2029
6.5.3 Japan Menkes Syndrome Market Size, 2018-2029
6.5.4 South Korea Menkes Syndrome Market Size, 2018-2029
6.5.5 Southeast Asia Menkes Syndrome Market Size, 2018-2029
6.5.6 India Menkes Syndrome Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Menkes Syndrome Revenue, 2018-2029
6.6.2 Brazil Menkes Syndrome Market Size, 2018-2029
6.6.3 Argentina Menkes Syndrome Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Menkes Syndrome Revenue, 2018-2029
6.7.2 Turkey Menkes Syndrome Market Size, 2018-2029
6.7.3 Israel Menkes Syndrome Market Size, 2018-2029
6.7.4 Saudi Arabia Menkes Syndrome Market Size, 2018-2029
6.7.5 UAE Menkes Syndrome Market Size, 2018-2029
7 Menkes Syndrome Companies Profiles
7.1 Fortress Biotech
7.1.1 Fortress Biotech Company Summary
7.1.2 Fortress Biotech Business Overview
7.1.3 Fortress Biotech Menkes Syndrome Major Product Offerings
7.1.4 Fortress Biotech Menkes Syndrome Revenue in Global Market (2018-2023)
7.1.5 Fortress Biotech Key News & Latest Developments
7.2 Teva Pharmaceutical Industries Ltd
7.2.1 Teva Pharmaceutical Industries Ltd Company Summary
7.2.2 Teva Pharmaceutical Industries Ltd Business Overview
7.2.3 Teva Pharmaceutical Industries Ltd Menkes Syndrome Major Product Offerings
7.2.4 Teva Pharmaceutical Industries Ltd Menkes Syndrome Revenue in Global Market (2018-2023)
7.2.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.3 Amerigen Pharmaceuticals Limited
7.3.1 Amerigen Pharmaceuticals Limited Company Summary
7.3.2 Amerigen Pharmaceuticals Limited Business Overview
7.3.3 Amerigen Pharmaceuticals Limited Menkes Syndrome Major Product Offerings
7.3.4 Amerigen Pharmaceuticals Limited Menkes Syndrome Revenue in Global Market (2018-2023)
7.3.5 Amerigen Pharmaceuticals Limited Key News & Latest Developments
7.4 Mylan N.V.
7.4.1 Mylan N.V. Company Summary
7.4.2 Mylan N.V. Business Overview
7.4.3 Mylan N.V. Menkes Syndrome Major Product Offerings
7.4.4 Mylan N.V. Menkes Syndrome Revenue in Global Market (2018-2023)
7.4.5 Mylan N.V. Key News & Latest Developments
7.5 Bausch Health
7.5.1 Bausch Health Company Summary
7.5.2 Bausch Health Business Overview
7.5.3 Bausch Health Menkes Syndrome Major Product Offerings
7.5.4 Bausch Health Menkes Syndrome Revenue in Global Market (2018-2023)
7.5.5 Bausch Health Key News & Latest Developments
7.6 H. Lundbeck A/S
7.6.1 H. Lundbeck A/S Company Summary
7.6.2 H. Lundbeck A/S Business Overview
7.6.3 H. Lundbeck A/S Menkes Syndrome Major Product Offerings
7.6.4 H. Lundbeck A/S Menkes Syndrome Revenue in Global Market (2018-2023)
7.6.5 H. Lundbeck A/S Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Menkes Syndrome Market Opportunities & Trends in Global Market
Table 2. Menkes Syndrome Market Drivers in Global Market
Table 3. Menkes Syndrome Market Restraints in Global Market
Table 4. Key Players of Menkes Syndrome in Global Market
Table 5. Top Menkes Syndrome Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Menkes Syndrome Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Menkes Syndrome Revenue Share by Companies, 2018-2023
Table 8. Global Companies Menkes Syndrome Product Type
Table 9. List of Global Tier 1 Menkes Syndrome Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Menkes Syndrome Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Menkes Syndrome Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Menkes Syndrome Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Menkes Syndrome Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Menkes Syndrome Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Menkes Syndrome Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Menkes Syndrome Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Menkes Syndrome Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Menkes Syndrome Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Menkes Syndrome Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Menkes Syndrome Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Menkes Syndrome Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Menkes Syndrome Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Menkes Syndrome Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Menkes Syndrome Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Menkes Syndrome Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Menkes Syndrome Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Menkes Syndrome Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Menkes Syndrome Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Menkes Syndrome Revenue, (US$, Mn), 2024-2029
Table 30. Fortress Biotech Company Summary
Table 31. Fortress Biotech Menkes Syndrome Product Offerings
Table 32. Fortress Biotech Menkes Syndrome Revenue (US$, Mn) & (2018-2023)
Table 33. Fortress Biotech Key News & Latest Developments
Table 34. Teva Pharmaceutical Industries Ltd Company Summary
Table 35. Teva Pharmaceutical Industries Ltd Menkes Syndrome Product Offerings
Table 36. Teva Pharmaceutical Industries Ltd Menkes Syndrome Revenue (US$, Mn) & (2018-2023)
Table 37. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 38. Amerigen Pharmaceuticals Limited Company Summary
Table 39. Amerigen Pharmaceuticals Limited Menkes Syndrome Product Offerings
Table 40. Amerigen Pharmaceuticals Limited Menkes Syndrome Revenue (US$, Mn) & (2018-2023)
Table 41. Amerigen Pharmaceuticals Limited Key News & Latest Developments
Table 42. Mylan N.V. Company Summary
Table 43. Mylan N.V. Menkes Syndrome Product Offerings
Table 44. Mylan N.V. Menkes Syndrome Revenue (US$, Mn) & (2018-2023)
Table 45. Mylan N.V. Key News & Latest Developments
Table 46. Bausch Health Company Summary
Table 47. Bausch Health Menkes Syndrome Product Offerings
Table 48. Bausch Health Menkes Syndrome Revenue (US$, Mn) & (2018-2023)
Table 49. Bausch Health Key News & Latest Developments
Table 50. H. Lundbeck A/S Company Summary
Table 51. H. Lundbeck A/S Menkes Syndrome Product Offerings
Table 52. H. Lundbeck A/S Menkes Syndrome Revenue (US$, Mn) & (2018-2023)
Table 53. H. Lundbeck A/S Key News & Latest Developments
List of Figures
Figure 1. Menkes Syndrome Segment by Type in 2022
Figure 2. Menkes Syndrome Segment by Application in 2022
Figure 3. Global Menkes Syndrome Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Menkes Syndrome Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Menkes Syndrome Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Menkes Syndrome Revenue in 2022
Figure 8. By Type - Global Menkes Syndrome Revenue Market Share, 2018-2029
Figure 9. By Application - Global Menkes Syndrome Revenue Market Share, 2018-2029
Figure 10. By Type - Global Menkes Syndrome Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Menkes Syndrome Revenue Market Share, 2018-2029
Figure 12. By Application - Global Menkes Syndrome Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Menkes Syndrome Revenue Market Share, 2018-2029
Figure 14. By Region - Global Menkes Syndrome Revenue Market Share, 2018-2029
Figure 15. By Country - North America Menkes Syndrome Revenue Market Share, 2018-2029
Figure 16. US Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Menkes Syndrome Revenue Market Share, 2018-2029
Figure 20. Germany Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 21. France Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Menkes Syndrome Revenue Market Share, 2018-2029
Figure 28. China Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 32. India Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Menkes Syndrome Revenue Market Share, 2018-2029
Figure 34. Brazil Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Menkes Syndrome Revenue Market Share, 2018-2029
Figure 37. Turkey Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Menkes Syndrome Revenue, (US$, Mn), 2018-2029
Figure 41. Fortress Biotech Menkes Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Teva Pharmaceutical Industries Ltd Menkes Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amerigen Pharmaceuticals Limited Menkes Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Mylan N.V. Menkes Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bausch Health Menkes Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. H. Lundbeck A/S Menkes Syndrome Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 万能細胞治療薬のグローバル市場展望 2023年-2029年：細胞治療、遺伝子治療、幹細胞治療
  • 遺伝性網膜疾患治療剤のグローバル市場展望 2023年-2029年：遺伝子治療、人工網膜、神経保護剤
  • 過敏性腸症候群治療薬のグローバル市場展望 2023年-2029年：IBS-D薬、IBS-C薬、その他
  • レストレスレッグス症候群治療のグローバル市場展望 2023年-2029年：一次性レストレスレッグス症候群、二次性レストレスレッグス症候群
  • HIV-梅毒-HBV-HCVコンボ迅速検査キットのグローバル市場展望 2023年-2029年：コロイダルゴールド、イムノアッセイ、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC12394 )"メンクス症候群のグローバル市場展望 2023年-2029年：遺伝子治療、銅注射療法" (英文：Menkes Syndrome Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。